We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
Cap. Flow
-$4.5B
Cap. Flow %
-4.19%
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 11.39%
3 Healthcare 9.26%
4 Consumer Discretionary 6.73%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBIO
2651
Crescent Biopharma
CBIO
$608M
$1.34M ﹤0.01%
826
+707
+594% +$1.47M
MNTA
2652
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.34M ﹤0.01%
73,707
-21,714
-23% -$362K
CENX icon
2653
Century Aluminum
CENX
$4.66B
$1.34M ﹤0.01%
80,890
+5,440
+7% +$114K
RMAX icon
2654
RE/MAX Holdings
RMAX
$207M
$1.34M ﹤0.01%
22,125
-828
-4% -$43.4K
ARCB icon
2655
ArcBest
ARCB
$3.23B
$1.34M ﹤0.01%
41,699
+13,658
+49% +$476K
AZZ icon
2656
AZZ Inc
AZZ
$4.59B
$1.34M ﹤0.01%
30,569
-180
-0.6% -$8.05K
CASH icon
2657
Pathward Financial
CASH
$1.89B
$1.33M ﹤0.01%
36,657
+7,173
+24% +$256K
SFNC icon
2658
Simmons First National
SFNC
$3.48B
$1.33M ﹤0.01%
46,863
-20,155
-30% -$590K
PMT
2659
PennyMac Mortgage Investment
PMT
$831M
$1.33M ﹤0.01%
73,927
-8,446
-10% -$141K
USNA icon
2660
Usana Health Sciences
USNA
$421M
$1.33M ﹤0.01%
15,518
+1,431
+10% +$111K
COBZ
2661
DELISTED
CoBiz Financial,Inc
COBZ
$1.33M ﹤0.01%
67,850
+1,539
+2% +$30.9K
TBPH icon
2662
Theravance Biopharma
TBPH
$875M
$1.33M ﹤0.01%
54,849
+8,757
+19% +$241K
STBZ
2663
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.33M ﹤0.01%
44,348
-15,422
-26% -$465K
UCB
2664
United Community Banks
UCB
$4.33B
$1.32M ﹤0.01%
41,658
-4,495
-10% -$141K
FIDI icon
2665
Fidelity International High Dividend ETF
FIDI
$361M
$1.32M ﹤0.01%
+57,670
New +$1.37M
KAI icon
2666
Kadant
KAI
$3.95B
$1.32M ﹤0.01%
13,919
-814
-6% -$80K
PLOW icon
2667
Douglas Dynamics
PLOW
$1.03B
$1.31M ﹤0.01%
30,320
+5,593
+23% +$232K
COOP
2668
DELISTED
Mr. Cooper
COOP
$1.31M ﹤0.01%
77,121
-2,580
-3% -$35.3K
EPOL icon
2669
iShares MSCI Poland ETF
EPOL
$754M
$1.31M ﹤0.01%
52,302
-97,698
-65% -$2.68M
NBTB icon
2670
NBT Bancorp
NBTB
$2.8B
$1.31M ﹤0.01%
36,874
+380
+1% +$13.9K
AMSF icon
2671
AMERISAFE
AMSF
$557M
$1.31M ﹤0.01%
23,633
-1,224
-5% -$71.4K
UMC icon
2672
United Microelectronic
UMC
$51.7B
$1.3M ﹤0.01%
+503,761
New +$1.25M
GPMT
2673
Granite Point Mortgage Trust
GPMT
$70M
$1.3M ﹤0.01%
78,812
+23,475
+42% +$404K
NSIT icon
2674
Insight Enterprises
NSIT
$4.15B
$1.3M ﹤0.01%
37,330
+6,042
+19% +$219K
SMH icon
2675
PUT
VanEck Semiconductor ETF
SMH
$72.3B
$1.3M ﹤0.01%
25,000
-500,000
-95% -$26.3M

Similar funds

Credit Suisse's Q1 2018 Portfolio in Review

As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.

  • Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
  • Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
  • Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
  • Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
  • Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
  • Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
  • Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.